Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

Coronavirus Covid-19 omicron mutation. Freshfields has won a Düsseldorf regional court patent dispute on behalf of client Moderna against German COVID-19 vaccine inventors BioNTech and Pfizer ...

The European Patent Office has said it has invalidated a patent held by Moderna on mRNA-based COVID-19 vaccines, the latest development in an increasingly acrimonious dispute between the company ...

Reuters, Sept. 16, 2021, Fact Check-COVID-19 vaccine was not being developed before the outbreak Reuters, Aug. 26, Moderna sues Pfizer/BioNTech for patent infringement over Covid vaccine ...

Covid-19 vaccine patent legal battle heading to Court of Appeal Moderna, Pfizer and BioNTech are locked in dispute over the rights to vaccine technology patents.

BioNTech, a biotech company best known for its successful development of a messenger RNA Covid-19 vaccine, is acquiring fellow mRNA company CureVac in a $1.25 billion stock deal that brings ...

Experts warn about risks of new COVID-19 vaccine guidelines 04:32. The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for ...

The University of Pennsylvania expects to receive $467 million from a German COVID-19 vaccine manufacturer after the pair settled a lawsuit out of court in late December 2024.

Learn more about the upcoming Covid-19 vaccine doses, including when you'll be able to get the shot, what it targets and more.

Penn expecting $467M windfall from COVID-19 vaccine royalty dispute. At issue was how much the manufacturer could carve out to third parties before paying the university its stake of the profits in ...